A Pfizer spokesman said on Thursday that the company does not expect to cut jobs at the Portage plant where it manufactures the Covid-19 vaccine it developed with German company BioNTech.
On Wednesday the company noted in a press release that the FDA had approved Pfizer and BioNTech’s “Comirnaty” Covid vaccine “for use in adults ages 65 and older, as well as individuals ages 5 through 64 years with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19.”
As previous versions of the vaccine were also authorized for healthy children and healthy adults, this week’s announcement marks a major shift in who is eligible to receive them…